Long-term Top 10 — Industrials — 18 Aug 2026

Growth 96th (3-year revenue CAGR 30%, revenue growth year over year 46.1%) and financial health 83rd (debt to equity 0, free cash flow margin 19.2%); weakest is valuation (16th, price to book 13.4, price to earnings 42.7).

• Profitability71.4
• Growth96.3
• Financial health83.1
• Valuation15.6
• Shareholder return70.8
• Long-term trend72.8

Financial health 97th (debt to equity 0, free cash flow margin 46.7%) and growth 85th (3-year revenue CAGR 27.6%, revenue growth year over year 14.5%); weakest is valuation (13th, price to book 10.7, price to earnings 48.6).

• Profitability65.3
• Growth84.7
• Financial health97.2
• Valuation13.4
• Shareholder return70.8
• Long-term trend71.4

Profitability 89th (return on equity 45.1%, operating margin 38.6%) and growth 74th (revenue growth year over year 16.9%, 3-year revenue CAGR 9.2%); weakest is valuation (41st, price to book 9.8, price to earnings 24.3).

• Profitability88.7
• Growth74.3
• Financial health61.9
• Valuation40.6
• Shareholder return70.8
• Long-term trend55.2

Financial health 77th (debt to equity 0.1, free cash flow margin 16.8%) and growth 73rd (revenue growth year over year 16.4%, 3-year revenue CAGR 8.5%); weakest is valuation (52nd, price to book 3.5, price to earnings 25.2).

• Profitability57.5
• Growth72.5
• Financial health77.1
• Valuation51.9
• Shareholder return70.8
• Long-term trend64.6

Financial health 87th (debt to equity 0, free cash flow margin 21.1%) and growth 72nd (3-year revenue CAGR 27.5%, revenue growth year over year 7%); weakest is valuation (25th, price to book 5.7, price to earnings 39.6).

• Profitability69.5
• Growth71.7
• Financial health87.2
• Valuation25.1
• Shareholder return70.8
• Long-term trend63.7

Financial health 73rd (debt to equity 0, free cash flow margin 13.1%) and long-term trend 73rd (a "golden cross" — its 50-day average is above its 200-day); weakest is valuation (35th, price to book 4.5, price to earnings 33.6).

• Profitability61.3
• Growth70.0
• Financial health73.1
• Valuation34.7
• Shareholder return70.8
• Long-term trend72.5

Growth 84th (3-year revenue CAGR 15.3%, revenue growth year over year 18.9%) and shareholder return 71st (consecutive years of dividend increases 5 years); weakest is valuation (40th, price to book 7.5, price to earnings 25.7).

• Profitability58.3
• Growth83.8
• Financial health59.2
• Valuation40.1
• Shareholder return70.8
• Long-term trend67.3

Growth 94th (revenue growth year over year 46.2%, 3-year revenue CAGR 19.3%) and long-term trend 74th (over the past 12 months this stock beat the market by 64.8 percentage points); weakest is valuation (25th, price to earnings 46.6, price to book 4.4).

• Profitability53.5
• Growth93.5
• Financial health59.4
• Valuation24.5
• Shareholder return70.8
• Long-term trend73.5

Growth 81st (3-year revenue CAGR 13.4%, revenue growth year over year 18.1%) and profitability 79th (return on equity 34.4%, operating margin 27.2%); weakest is valuation (8th, price to book 15.4, price to earnings 59.9).

• Profitability79.3
• Growth81.4
• Financial health60.3
• Valuation8.1
• Shareholder return70.8
• Long-term trend70.3

Financial health 77th (debt to equity 0, free cash flow margin 14.3%) and profitability 72nd (return on equity 25.9%, operating margin 22.9%); weakest is long-term trend (51st, a strong downtrend, with sellers in control).

• Profitability71.6
• Growth53.1
• Financial health76.5
• Valuation60.6
• Shareholder return70.8
• Long-term trend50.5